Surgical products company Ethicon Endo-Surgery, a division of Johnson & Johnson (NYSE:JNJ), is entering the medical device reprocessing and remanufacturing business with a planned acquisition of SterilMed.The price of the deal isn’t being disclosed, according to a statement from Cincinnati-based Ethicon.With the cost of healthcare in the U.S. continuing to skyrocket, medical device reprocessing could [...]
[Read more of this report]The Food and Drug Administration has reconsidered its denial of Ethicon Endo-Surgery Inc.’s application to begin selling a computer-assisted sedation system.
[Read more of this report]Surgical device company Ethicon Endo-Surgery Inc. has appealed the federal government’s denial of its application to begin selling a sedation system for colonoscopy and upper gastrointestinal procedures.
[Read more of this report]Devicor Medical Products Group LLC, the medical device holding company that bought the breast-care business of Johnson & Johnson‘s Ethicon Endo-Surgery two weeks ago, has raised $151.5 million.Devicor Medical in Pleasant Prairie, Wisconsin raised the money from seven investors, beginning on July 9, according to a Securities and Exchange Commission (SEC) filing. Nearly $3.4 million [...]
[Read more of this report]Devicor Medical Products Inc., the Pleasant Valley, Wisconsin, fledgling holding company backed by Chicago private equity firm GTCR Golder Rauner LLC, has made its first acquisition: the breast care business of Johnson & Johnson’s Ethicon Endo-Surgery unit near Cincinnati, Ohio.Financial terms of the deal were not disclosed.But nearly 300 Ethicon Endo-Surgery employees who are connected [...]
[Read more of this report]Device firm Ethicon Endo-Surgery Inc. has awarded a $13.5 million grant to the University of Cincinnati and others for collaborative obesity research.The three-year grant will be used to investigate how and why gastric bypass surgery works, according to a statement from Ethicon Endo-Surgery. Gastric bypass surgery often helps patients lose weight and can also cure [...]
[Read more of this report]Johnson & Johnson (NYSE:JNJ) provided investors and analysts with a glimpse into its medical device operation, which it called the world’s largest.Over the past two years, according to the presentation, the division posted $1.8 billion in operational sales growth (excluding special items such as acquisitions or legal expenses). The segment’s total [...]
[Read more of this report]Ethicon Endo-Surgery Inc. is entertaining an offer from a private equity-backed holding company for its breast care business, including the MammoTome biopsy system.The Johnson & Johnson (NYSE:JNJ) subsidiary has until June 15 to decide whether to accept the offer from Devicor Medical Products, a portfolio company of GTCR Golder Rauner LLC. Specific terms of the [...]
[Read more of this report]Ethicon Endo-Surgery Inc. and a subsidiary of Hologic Inc. have settled their patent infringement disagreements with a $12.5 million payment to Ethicon and the promise to share royalties from selling each other’s breast cancer biopsy devices.
[Read more of this report]A federal judge in Georgia ordered Johnson & Johnson subsidiary Ethicon Endo-Surgery to produce documents subpoenaed in a product liability lawsuit over Mentor Corp.’s ObTape bladder sling.
[Read more of this report]